| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004613802 |
| P356 | DOI | 10.1038/313491A0 |
| P698 | PubMed publication ID | 3871510 |
| P2093 | author name string | Brown JP | |
| Todaro GJ | |||
| Twardzik DR | |||
| Marquardt H | |||
| P2860 | cites work | Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor | Q40135209 |
| Synthesis of biologically active rat transforming growth factor I. | Q41584596 | ||
| A TRANSMISSIBLE TUMOR-LIKE CONDITION IN RABBITS | Q42794964 | ||
| Abortive infection and transformation of human embryonic fibroblasts by Molluscum contagiosum virus | Q45208217 | ||
| Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus | Q45798186 | ||
| Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins | Q48397396 | ||
| Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor | Q53553601 | ||
| Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. | Q53554133 | ||
| Molluscum contagiosum | Q69929708 | ||
| Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor | Q24301384 | ||
| Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors | Q24606243 | ||
| Empirical Predictions of Protein Conformation | Q28300310 | ||
| Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells | Q29616544 | ||
| Epidermal Growth Factor | Q34192014 | ||
| Computer-based characterization of epidermal growth factor precursor | Q34264382 | ||
| Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor | Q37344260 | ||
| Dissimilation of glucose by the MX strain of Rhizopus | Q37462146 | ||
| P433 | issue | 6002 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vaccinia virus | Q1986297 |
| P304 | page(s) | 491-492 | |
| P577 | publication date | 1985-02-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor | |
| P478 | volume | 313 |
| Q40791679 | A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. |
| Q34585582 | A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication |
| Q44902213 | Amino acids bracketing the predicted transmembrane domains of membrane proteins |
| Q33275923 | An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation |
| Q35689619 | An overview of the vaccinia virus infectome: a survey of the proteins of the poxvirus-infected cell |
| Q41703831 | Assessment of biological activity of synthetic fragments of transforming growth factor α |
| Q34369297 | Bacteriophage PRD1 DNA polymerase: evolution of DNA polymerases |
| Q44171115 | Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies. |
| Q45784355 | Changes in epidermal Langerhans cells, gamma delta T cells and CD4 T cells after intradermal infection with recombinant vaccinia virus expressing cytokine genes |
| Q40130035 | Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum |
| Q34192457 | Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha |
| Q35777995 | Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species |
| Q36908904 | DNA sequence homology between the terminal inverted repeats of Shope fibroma virus and an endogenous cellular plasmid species |
| Q34096401 | Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling |
| Q36699676 | Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor |
| Q36876074 | Deletion of the vaccinia virus growth factor gene reduces virus virulence |
| Q40897812 | Differential roles of the Src homology 2 domains of phospholipase C-gamma1 (PLC-gamma1) in platelet-derived growth factor-induced activation of PLC-gamma1 in intact cells |
| Q40681979 | Downregulation of the epidermal growth factor receptor by human cytomegalovirus infection in human fetal lung fibroblasts |
| Q37529665 | Epidermal growth factor and related growth factors |
| Q36844512 | Epidermal growth factor and transforming growth factor α |
| Q35613503 | Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair |
| Q45837541 | Epidermal growth factor receptor occupancy inhibits vaccinia virus infection |
| Q35831275 | Epidermal growth factor receptors in idiopathic and virally induced skin diseases |
| Q40623950 | Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. |
| Q28306342 | Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules |
| Q28727937 | Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA |
| Q42518413 | Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study |
| Q37480208 | Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells |
| Q36872185 | Growth factor production by Creutzfeldt-Jakob disease cell lines |
| Q39500167 | Growth factors in cancer and their relationship to oncogenes |
| Q35607469 | Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene |
| Q28115244 | Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization |
| Q36827070 | Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicated in binding the beta receptor. |
| Q35830307 | Isolation of a monoclonal antibody which blocks vaccinia virus infection. |
| Q38202242 | Keratinocytes produce and are regulated by transforming growth factors |
| Q37392431 | Localization and sequence of a vaccinia virus gene required for multiplication in human cells |
| Q36886902 | Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha |
| Q67802653 | Mapping the receptor-recognition site of human transforming growth factor-α |
| Q50533334 | Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory. |
| Q24567485 | Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells |
| Q36426104 | Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene |
| Q35226993 | Molecular mechanisms for generation of neural diversity and specificity: roles of polypeptide factors in development of postmitotic neurons |
| Q36884106 | Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters |
| Q45776975 | Mumps virus alters aggregation of acetylcholine receptors in cultured rat skeletal muscle cells |
| Q41355397 | Myxoma T2 protein as a model for poxvirus TNF receptor homologs |
| Q36664516 | Neovascular growth factors |
| Q35403506 | Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion |
| Q42657008 | Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network |
| Q37202069 | Phylogenetic and histological variation in avipoxviruses isolated in South Africa |
| Q37954175 | Polypeptide growth factors and the kidney: a developmental perspective |
| Q34055804 | Poxvirus homologues of cellular genes |
| Q24634729 | Poxvirus pathogenesis |
| Q48038491 | Purification and characterization of a recombinant human cripto-1 protein |
| Q34490252 | Redundancy complicates the definition of essential genes for vaccinia virus |
| Q69875933 | Retroviral gag and DNA endonuclease coding sequences in IgE-binding factor gene |
| Q28288029 | Shuffled domains in extracellular proteins |
| Q59098143 | Similarity of vaccinia 28K, v-erb-B and EGF receptors |
| Q38293481 | Site-directed mutagenesis of heparin-binding EGF-like growth factor (HB-EGF): analysis of O-glycosylation sites and properties |
| Q42041069 | Stimulation of cell motility by a viral fibroblast growth factor homolog: proposal for a role in viral pathogenesis |
| Q39698408 | Structural and functional aspects of epidermal growth factor (EGF) and its receptor. |
| Q33680363 | Structure and function of epigen, the last EGFR ligand |
| Q47199024 | Structure optimization to improve the delivery efficiency and cell selectivity of a tumor-targeting cell-penetrating peptide |
| Q42793438 | Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis |
| Q27472897 | Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase |
| Q36694749 | The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor |
| Q39323853 | The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation. |
| Q48162492 | The Drosophila spitz gene encodes a putative EGF-like growth factor involved in dorsal-ventral axis formation and neurogenesis |
| Q54120212 | The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells. |
| Q24600473 | The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity |
| Q41064456 | The drosophila dorsoventral patterning gene gurken produces a dorsally localized RNA and encodes a TGFα-like protein |
| Q36834422 | The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha |
| Q41704313 | The molecular biology of swinepox virus II. The infectious cycle |
| Q35876204 | The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers |
| Q33779090 | The role of the epidermal growth factor receptor in microbial infections of the gastrointestinal tract. |
| Q36667899 | The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells |
| Q40577848 | The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. |
| Q36852325 | Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions |
| Q36854635 | Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b |
| Q35608343 | Transforming growth factor alpha inhibits secretion of gastric acid |
| Q39573228 | Transforming growth factors in the regulation of malignant cell growth and invasion |
| Q36728801 | Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design |
| Q35854551 | Vaccinia virions lacking core protein VP8 are deficient in early transcription |
| Q28297889 | Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins |
| Q36909038 | Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors |
| Q39698568 | Vaccinia virus regulates expression of p21WAF1/Cip1 in A431 cells. |
| Q37527595 | Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors |
| Q42023832 | Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection |
| Q34629086 | Varicella-zoster virus as a live vector for the expression of foreign genes |
| Q39318787 | Viral exploitation of the MEK/ERK pathway - A tale of vaccinia virus and other viruses |
| Q54269214 | Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: A paradigm shift for host-microbe interactions. |
| Q41374895 | Virocrine transformation |
| Q40874328 | Virus infection of polarized epithelial cells |
| Q35221338 | What's new in the role of cytokines on osteoblast proliferation and differentiation? |
Search more.